168 Letters in Organic Chemistry, 2011, Vol. 8, No. 3
Lei et al.
Compound 4h
148.3, 139.1, 130.7, 129.8, 121.5, 120.1, 117.9, 117.2, 68.4,
64.3, 63.4, 36.7, 25.9, 22.4, 19.8, 18.1, -4.0, -4.9. Anal.
Calcd for C23H35N5O3Si: C, 60.36; H, 7.71; N, 15.30. Found:
C, 60.30; H, 7.69; N 15.35.
Yield 90%; White solid; [ꢀ]D20 = +39.6 (c 0.10, CH3CN);
mp 137.3-137.9 ˚C. MS (ESI): m/z :377.2[M+Na+]. IR
(KBr): 3217, 1776, 1752cm-1. 1H NMR (CDCl3): ꢀ = 7.72 (s,
1H), 6.80 (1H, br s, -NH), 6.26 (1H, d, J = 0.95Hz, 4-H),
4.33-4.35 (1H, m), 3.52 (1H, dd, J = 2.7, 1.9 Hz, 3-H), 2.69
(1H, br s, -OH), 1.64 (6H, s), 1.27 (3H, d, J = 6.3Hz), 0.90
(9H s,), 0.11 and 0.10 (total 6H, each s). 13C NMR (CDCl3):
ꢀ = 166.5, 156.8, 117.1, 68.8, 68.5, 64.3, 63.3, 30.6, 25.9,
22.5, 18.2, -4.0, -4.9. Anal. Calcd for C16H30N4O3Si: C,
54.21; H, 8.53; N, 15.80. Found: C, 54.12; H, 8.54; N 15.73.
Compound 6
20
Yield 93%; White solid; [ꢀ]D = +73.5 (c 0.10,
CH3CN); mp: 184.0-184.2 ˚C. MS (ESI): m/z 309.2[M+Na+],
287.2[M+H+]. IR (KBr): 3448, 2960, 1786, 1259, 846 cm-1.
1H NMR (d -DMSO): ꢀ = 9.04 (1H, br s, -NH), 8.87 (1H, s),
6
7.78 (2H, d, J = 7.9), 7.29 (2H, d, J = 7.9), 6.15 (1H, s, 4-H),
5.19 (1H, -OH), 4.05 (1H, m), 3.64 (1H, m, 3-H), 2.61-2.66
(q, 2H, J = 7.5Hz), 1.17-1.22 (6H, m). 13C NMR (d6-
DMSO): ꢀ = 167.0, 147.5, 144.2, 128.7, 128.4, 125.7, 119.8,
67.2, 63.5, 63.3, 28.4, 22.1, 15.9. Anal. Calcd for
C15H18N4O22: C, 62.92; H, 6.34; N, 19.57. Found: C, 62.81;
H, 6.38; N 19.61.
Compound 4i
Yield 90%; White solid; [ꢀ]D20 = +25.5 (c 0.10, CH3CN);
mp: 139.4-140.6 ˚C. MS (ESI): m/z 376.9[M+Na+]. IR
(KBr): 2951, 1788, 1745, 1374, 1214, 1042 cm-11H NMR
(CDCl3): ꢀ = 8.41 (1H, s),7.08 (1H, br s, -NH), 6.35 (1H, s,
4-H), 4.34-4.35 (1H, m), 3.95 (3H, s,-OCH ), 3.56 (1H, m,
3
3-H), 1.28 (3H, d, J = 6.4Hz), 0.88 (9H, s),0.11 and 0.10
ACKNOWLEDGEMENT
(total 6H, each s). 13C NMR (CDCl3): ꢀ = 166.1, 161.0,
140.8, 125.7, 68.9, 64.3, 63.7, 52.6, 25.9, 22.4, 18.1, -4.0, -
4.9. Anal. Calcd for C15H26N4O4Si: C, 50.82; H, 7.39; N,
15.81. Found: C, 50.97; H, 7.35; N 15.87.
We thank Dr. W. Xu for his X-ray crystallographic
analysis.
Compound 4j
REFERENCES AND NOTES
Yield 90%; White solid; [ꢀ]D20 = +22.0 (c 0.10, CH3CN);
mp: 142.1-143.9 ˚C. MS (ESI): m/z 390.9[M+Na+]. IR
(KBr): 2936, 1790, 1739, 1209, 1040cm-1. 1H NMR
(CDCl3): ꢀ = 8.39 (1H, s), 7.14 (1H, br s, -NH), 6.34 (1H, s,
4-H), 4.41 (2H, q, J = 7.2Hz), 4.34-4.35 (1H, m), 3.54 (1H,
m, 3-H), 1.40 (3H, t, J = 7.2Hz), 1.27 (3H, d, J = 6.4Hz),
0.87 (9H, s), 0.10 and 0.08 (total 6H, each s). 13C NMR
(CDCl3): ꢀ = 166.2, 160.6, 141.0, 125.6, 68.9, 64.3,
63.6,61.8, 25.9, 22.4, 18.1, 14.5, -4.0, -4.9. Anal. Calcd for
C16H28N4O4Si: C, 52.15; H, 7.66; N, 15.20. Found: C, 52.13;
H, 7.62; N 15.22.
[1]
(a) Chemistry and Biology of ꢀ-Lactam Antibiotics; Morin, R.B.;
Gorman, M. Eds.; Academic Press: New York, 1982; (b) The
Organic Chemistry of ꢀ-Lactams; Georg, G.I. Ed.; Verlag Chemie:
New York, 1993 and references therein; (c) Neuhaus, F.C.;
Georgopapadaku, N. H. In: Emerging Targets in Antibacterial and
Antifungal Chemotherapy; Sutcliffe, J.; Georgopapadakou, N.H.
Eds.; Chapman and Hall: New York, 1992.
(a) Staub, I.; Sieber, S.A. ꢁ-Lactam probes as selective chemical-
proteomic tools for the identification and functional
characterization of resistance associated enzymes in MRSA. J. Am.
Chem. Soc., 2009, 131, 6271-6276; (b) Brandi, A.; Cicchi, S.;
Cordero, F.M. Novel syntheses of azetidines and azetidinones.
Chem. Rev., 2008, 108, 3988-4035; (c) Alcaide, B.; Almendros, P.;
Aragoncillo, C. ꢁ-Lactams: versatile building blocks for the
stereoselective synthesis of non-ꢁ-lactam products. Chem. Rev.,
2007, 107, 4437-4492; (d) Zhang, X.J.; Hsung, R.P.; Li, H.Y.;
Zhang, Y.; Johnson W.L.; Figueroa, R. A highly stereoselective
synthesis of chiral alpha-amino-ꢁ-lactams via the Kinugasa
reaction employing ynamides. Org. Lett., 2008, 10, 3477-3479.
Kidwai, M.; Sapra, P.; Bhushan, K.R. Synthetic strategies and
medicinal properties of ꢁ-lactams. Curr. Med. Chem., 1999, 6, 195-
215.
Bulychev, A.; Bellettini, J.R.; O’Brien, M.; Crocker, P. J.;
Samama, J.P.; Miller, M.J.; Mobashery, S. N-sulfonyloxy-ꢁ-lactam
inhibitors for ꢁ-lactamases. Tetrahedron, 2000, 56, 5719-5728.
(a) Page, M.I.; Laws, A.P. The chemical reactivity of ꢁ-lactams, ꢁ-
sultams and ꢁ-phospholactams. Tetrahedron, 2000, 56, 5631-5637;
(b) Buynak, J.D.; Rao, A.S.; Ford, G.P.; Carver, C.; Adam, G.;
Geng, B.; Bachmann, B.; Shobassy, S.; Lackey, S. 7-
Alkylidenecephalosporin esters as inhibitors of human leukocyte
elastase. J. Med. Chem., 1997, 40, 3423-3433 and references cited
therein.
[2]
Compound 4k
Yield 88%; Pale yellow solid. [ꢀ]D20 = +28.0 (c 0.10,
CH3CN); mp: 79.1-80.9 ˚C. MS (ESI): m/z 432.9[M+Na+],
410.9[M+H+]. IR (CH2Cl2): 3262, 2951, 1788, 1462, 1132,
832 cm-1. 1H NMR (CDCl3): ꢀ = 7.84 (1H, s), 7.31 (1H, br s,
-NH), 6.26 (1H, s, 4-H), 4.86 (1H, m), 4.73-4.74 (1H, m),
4.61 (1H, m), 4.32-4.34 (1H, m), 3.89 (1H, m), 3.53 (1H, m),
1.60-1.73 (2H, m), 1.52-1.60 (4H, m), 1.25 (3H, t, J =
6.4Hz), 0.89 (9H, s), 0.11 and 0.10 (total 6H, each s).
13C NMR (CDCl3): ꢀ = 166.7, 146.2, 120.4, 98.6, 68.3,
64.2, 63.2, 62.5, 60.6, 30.5, 25.8, 25.4, 22.4, 19.5, 18.1, -4.1,
-4.9. Anal. Calcd for C19H34N4O4Si: C, 55.58; H, 8.35; N,
13.65. Found: C, 55.52; H, 8.40; N 13.58.
[3]
[4]
[5]
[6]
Kværnø, L.; Werder, M.; Hauser, H.; Carreira, E.M. Synthesis and
in vitro evaluation of inhibitors of intestinal cholesterol absorption.
J. Med. Chem., 2005, 48, 6035-6053.
Huisgen, R. In: 1,3-Dipolar Cycloaddition Chemistry; Padwa, A.,
Ed.; Wiley: New York, 1984.
(a) Park, I.S.; Kwon, M.S.; Kim, Y.; Lee, J.S.; Park, J.
Heterogeneous copper catalyst for the cycloaddition of azides and
alkynes without additives under ambient conditions. Org. Lett.,
2008, 10, 497-500; (b) Kumar, A.; Pandey, P.S. Anion recognition
by 1,2,3-triazolium receptors: application of click chemistry in
anion recognition. Org. Lett., 2008, 10, 165-168; (c) Geng, J.;
Lindqvist, J.; Mantovani, G.; Haddleton, D.M. Simultaneous
copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) and
Compound 4l
Yield 90%; White solid; [ꢀ]D20 = +48.2 (c 0.10, CH3CN);
mp: 95.1-97.2 ˚C. MS (ESI): m/z 479.9[M+Na+],
457.8[M+H+]. IR (KBr): 3317, 2958, 2930, 1775, 1376,
[7]
[8]
1
1252cm-1. H NMR (CDCl3): ꢀ = 8.02(1H, s), 8.01 (1H, s),
7.94 (1H, s), 7.79 (1H, br s, -NH), 7.57-7.59 (1H, m), 7.47-
7.49 (1H,m), 7.27-7.32 (1H, m), 6,27 (1H,s, 4-H), 4.33-4.35
(1H, m), 3.57 (1H, m, 3-H), 2.58 (1H, m), 1.26 (3H, t, J =
6.3Hz), 1.24 (6H, m, J = 6.8Hz), 0.85 (9H, s), 0.10 and 0.09
(total 6H, each s). 13C NMR (CDCl3): ꢀ = 176.3, 166.8,